Further on, we demonstrate that PACAP exerted not only beneficial anti-inflammatory effects on cerebral toxoplasmosis, but also showed a neuroprotective outcome in the infected brain parenchyma. The gene discussed is ADCYAP1; the disease is cerebral toxoplasmosis.